Health Care & Life Sciences » Pharmaceuticals | Windtree Therapeutics Inc.

Windtree Therapeutics Inc.

Windtree Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$5.29
Market Cap
$136 M
Shares Outstanding
32.13 M
Public Float
6.57 M

Profile

Address
2600 Kelly Road
Warrington Pennsylvania 18976
United States
Employees -
Website http://www.windtreetx.com
Updated 07/08/2019
Windtree Therapeutics, Inc. engages in the manufacture and development of products for infants and respiratory diseases. It focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. The company was founded by Evan Myrianthopoulos and James S.

Financials

View All
Created with Highcharts 5.0.14Windtree Therapeutics Inc.Net Income. Fiscal year is January-December. All values USD Thousands.45 21545 21544 05844 05855 17055 17039 49039 49018 44618 44633 03833 038201320142015201620172018010k20k30k40k50k60k
Created with Highcharts 5.0.14Windtree Therapeutics Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.3883882 8352 8359879872 0422 0421 4851 4851 7881 788201320142015201620172018050010001500200025003000

Craig E. Fraser
President, Chief Executive Officer & Director
John R. Leone
Chairman